4//SEC Filing
Van Hauwermeiren Timothy 4
Accession 0001816206-25-000007
CIK 0001714899other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:16 PM ET
Size
7.6 KB
Accession
0001816206-25-000007
Insider Transaction Report
Form 4
Van Hauwermeiren Timothy
Director
Transactions
- Award
Common Stock
2025-11-04+10,632→ 10,632 total - Award
Stock Option (right to buy)
2025-11-04+31,897→ 31,897 totalExercise: $14.92Exp: 2034-11-04→ Common Stock (31,897 underlying)
Footnotes (3)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. The RSU award vests over a four-year period, with 1/4th of the shares vesting on each anniversary of the grant date (or, for the last tranche that otherwise would vest on the fourth anniversary of the grant date, on such anniversary or, if earlier, on the day prior to the Company's next annual meeting of stockholders occurring after the third anniversary of the grant date), provided that he remains a non-employee director through the applicable vesting date.
- [F2]Includes 10,632 unvested RSUs.
- [F3]25% of the shares subject to the option shall vest on November 4, 2026, and an additional 1/48 of the shares subject to the option vest each month thereafter, subject to the Reporting Person remaining a non-employee director of the Issuer through each such date
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001816206
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 8:16 PM ET
- Size
- 7.6 KB